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We previously devised cell-free conditions supporting efficient replication of bovine papillomavirus type 1
(BPV1) DNA (C. Bonne-Andre´a, S. Santucci, and P. Clertant, J. Virol. 69:3201–3205, 1995): the use of highly
active preparations of viral initiator protein E1, together with extract from a particular cell source, allowed the
synthesis of complete DNA circles through successive rounds of replication; this occurred in the absence of the
viral transcriptional activator E2, required in vivo for the replication of viral genomes. We now report that
adding E2 to cell-free assays produced only slight effects both on the yield of E1-dependent DNA synthesis and
on the quality of newly made DNA molecules when a template carrying a wild-type BPV1 replication origin (ori)
was used. The performance of mouse cell extracts, unable to sustain efficient BPV1 DNA replication in the
presence of E1 only, was likewise not improved by the addition of E2. In a proper in vitro environment, E1 is
thus fully capable of efficiently initiating viral DNA synthesis by itself, an activity which is not enhanced by
interaction with E2. An important effect, however, was detected: E2 totally suppressed the nonspecific repli-
cation of ori-defective DNA templates, otherwise observed in high E1 concentrations. We examined the
requirements for building a minimal DNA sequence behaving in vitro as a specific ori sequence under stringent
recognition conditions, i.e., in the presence of both E1 and E2. Only two elements, the 18-bp E1 binding
palindrome and an AT-rich sequence, were required in cis to allow specific cell-free DNA replication; there
seemed to be no need for an E2 binding site to ensure discrimination between specific ori templates and other
DNA molecules, even in the presence of E2. This suggests that during the initiation of BPV1 DNA replication,
at least in vitro, E2 acts as a specificity factor restricting the action of E1 to a defined ori sequence; this
function, likely not demanding the direct binding of E2 to cognate DNA sites, might primarily involve
protein-protein interactions.
In eukaryotic cells, the initiation of DNA synthesis appears
to involve, in addition to specific mechanisms aimed at unwind-
ing the DNA double helix at defined locations along the ge-
nome, an auxiliary role for transcription factors (see reference
11 for a review). This has been evidenced by genetic analyses of
the elements controlling in cis the start of DNA synthesis at
specific origins of replication (ori), like those of small onco-
genic DNA viruses infecting mammalian cells (polyomavirus
or simian virus 40 [SV40]) or the ars elements of baker’s yeast.
In all cases, the replication origins are made of (i) a central
core, containing both a defined sequence recognized by a spe-
cific initiator protein (large T antigen or ORC complex) and a
less defined sequence supposed to allow unwinding of the
DNA duplex by DNA helicases (an AT-rich sequence or du-
plex unwinding element [21]), and (ii) one or several adjacent
enhancer-like elements. The presence of auxiliary sequences
either greatly enhances the efficiency of firing up DNA synthe-
sis on the nearby core origin (for SV40) or is even required for
the occurrence of this process (for polyomavirus). ori auxiliary
sequences contain binding sites for transcription factors (AP-1
for polyomavirus, SP1 for SV40, and ABF1 for ars1), whose
expression is needed for their replicative function. To a certain
extent, they can be replaced by other sequences, which bind
other transcription factors of similar properties (12, 17). No-
tably enough, these enhancer elements are totally dispensable
for performing in vitro replication with naked templates in the
cases of SV40 and polyomavirus DNA. Consequently two
mechanisms have been invoked for explaining their role, with
experimental evidence supporting each of them: prevention of
the repression of DNA replication by a chromatin structure in
keeping the ori region accessible to initiator proteins (7, 8)
and/or tethering of proteins of the replication machinery for
cooperation with initiators already bound to the origin (18).
Papillomaviruses (PV) keep to this pattern with one impor-
tant peculiarity. Two viral proteins, E1 and E2, are normally
required for replicating PV DNA (54). E1 is similar to another
well-studied viral initiator protein, SV40-polyomavirus large T
antigen (10): E1 is a nuclear phosphoprotein (42, 51) with
DNA helicase and ATPase activities (30, 44, 46, 59) that is able
to recognize and unwind an 18-bp palindrome within the viral
replication origin (47, 49, 55, 56, 59). PV origins are short
sequences (less than 100 bp) comprising mainly an E1 binding
site and important flanking elements (see, for instance, refer-
ences 14 and 53) such as AT-rich sequences and one or several
binding sites for the second viral protein, transactivator E2.
The E2 open reading frame was initially discovered controlling
viral transcription, and it is expressed mainly in two forms (see
reference 31 for a review): (i) short variants with DNA binding
activity only, acting as repressors, and (ii) a larger protein,
possessing an additional domain for transcriptional activation.
Both forms exist as dimers and bind the same palindromic
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sequences dispersed at several places along the PV genome.
Only the larger form is needed for the replication of viral DNA
(54), so we will refer to it as protein E2 in this paper (the E2
repressors, which may play a role in modulating DNA replica-
tion, are likely not involved in the initiation process since they
are not needed for replication). At first sight, then, PV protein
E2 appears to be a viral counterpart to the host transcription
factors involved in helping the viral initiator of polyomavirus
and SV40. This statement is an oversimplification, however, for
two reasons. First, contrary to polyomavirus large T antigen
and cell transcription factors, which do not interact directly,
the E2 protein enters into stable molecular association with the
initiator E1 (2, 36), at least when properly modified by phos-
phorylation (28). Making a complex with E2 indeed greatly
modifies the binding of E1 to the ori region by both improving
affinity and lengthening the protected sequence (29, 45, 47, 58).
Second, while proteins E1 and E2 can be exchanged between
different papillomaviruses to ensure the replication of heter-
ologous origins (9, 14), the structure of the PV replication
origin varies notably depending on the virus type: in addition to
an E1 binding site and an AT-rich sequence, the bovine pap-
illomavirus type 1 (BPV1) ori contains a mandatory E2 binding
site (53); that of human papillomavirus type 11 (HPV11) and
HPV18 can be built of only two E2 sites, while requiring
proteins E1 and E2 for replication (41, 52). Finally, the repli-
cation of HPV1a DNA requires only the expression of E1, and
accordingly the HPV1a ori can be reduced to an E1 binding
site and an AT-rich sequence only (14). The evolution of the
PV family thus appears to have resulted in different scenarios,
albeit with the same casting of two conserved protein partners,
whose interactions with each other as well as with DNA targets
have remained invariable.
Notwithstanding the HPV1a exception, as a general rule the
E2 transactivator is required for viral DNA replication. Ge-
netic analysis has localized determinants for replicative func-
tion within the N-terminal part of the BPV1 E2 molecule, a
domain that is also required both for E1 binding and for
transcriptional activation (1, 5, 13, 15, 16, 57). Targeted mu-
tagenesis has allowed us to clearly distinguish between these
three functions, the binding of E1 being a likely prerequisite to
the replicative function of E2. It is generally considered that
the binding of E2 to its DNA targets is also involved in BPV1
DNA replication; two E2 mutations have, however, been de-
scribed as abolishing both DNA binding and transcriptional
activation but retaining dimerization and E1 binding capaci-
ties, with the result that the replicative function of the E2
protein has remained intact (15, 57). Knowing whether the role
played by E2 in viral DNA replication is mediated or not
through direct binding to a cognate site within the origin thus
deserves further attention.
Cell-free systems allowing PV DNA replication helped to
clarify the role of E2 to a certain extent. BPV1 DNA synthesis
in vitro was reported to occur in soluble extracts from mouse
cells in the presence of protein E1 (37, 45–47, 58, 59). It is well
established that, contrary to the in vivo situation, the cell-free
replication of polyomavirus and SV40 DNA does not depend
on either transcription factors or ori auxiliary sequences; how-
ever, the addition of E2 largely improved in vitro BPV1 DNA
synthesis by factors of from 4 to 20 (though the increase was
much lower than that observed in parallel for the binding of E1
to the ori sequence). Notably, even under optimal conditions
(i.e., in the presence of E2), limited yields of DNA synthesis
were obtained, amounting to only 5 to 20% of the levels usually
obtained for SV40 DNA replication in vitro (23, 50). Finally, in
the rare occurrences in which in vitro DNA synthesis was
characterized as being semiconservative, it was apparently lim-
ited to only one round of replication. Cell-free systems were
sufficient, however, to show that E2 could be replaced by other
acidic transcriptional activators, helping to tether the replica-
tion protein A to the origin of replication (24); their use also
helped illustrate how prior binding of E2 to ori DNA could
prevent the inhibition of replication exerted by the establish-
ment of nucleosomal structures in vitro (25). We recently re-
ported conditions sustaining much higher levels of cell-free
BPV1 DNA synthesis, satisfying both the criteria of semicon-
servation and bidirectionality on either side of the origin (3, 4).
Under these conditions BPV1 DNA synthesis is as efficient as
that of SV40 DNA in vitro and proceeds through successive
rounds of replication. As previously reported by others (47,
59), however, synthesis is not limited to specific ori DNA tem-
plates when high concentrations of protein E1 are used. These
findings indicated that E1 has a full capacity to initiate runaway
replication by itself, as do initiators of lytic viruses like SV40
large T antigen. Here we report that under the conditions
allowing highly efficient BPV1 DNA synthesis, the E2 protein
exerts only marginal effects on the replication of specific ori
DNA templates, while it totally suppresses that of nonspecific
DNA; moreover, in playing the role of a specificity factor, E2
does not seem to require the presence of a cognate binding site
within the ori sequence.
MATERIALS AND METHODS
Biological materials. The cell lines employed for preparing soluble extracts for
cell-free replication, the recombinant baculoviruses used for expressing the
BPV1 proteins into Sf9 cells, and the antibodies able to recognize these proteins
were described previously (4, 42, 44).
Plasmid DNAs used as templates for replication. The pSV-BPV11 composite
plasmid was described previously (3). The pSKori1 plasmid was built by inserting
within the EcoRV site of the pBluescript SK1 vector (Stratagene) a 160-bp
BPV1 DNA fragment (nucleotides [nt] 7855 to 81 in the viral genomic sequence
[6]) carrying what was defined as a minimal origin for BPV1 DNA replication
(55) together with an adjacent E2 binding site (E2BS-11 [26]). The replication-
defective derivative pSKori2 was obtained by inserting a 12-bp XhoI linker into
the HpaI site of the pSKori1 DNA, thus interrupting the palindromic 18-bp E1
binding site within the BPV1 ori sequence (19, 34, 53, 58). The capacity of these
constructs to behave as carrying a functional BPV1 replication origin was exam-
ined by assaying for transient replication after transfection into human 293 cells
expressing constitutively viral proteins E1 and E2, as will be described elsewhere
(40); as expected, the replication of pSKori1 DNA was very efficient (more than
500 copies/cell 72 h after transfection), while that of pSKori2 was undetectable.
Synthetic origins of replication were constructed by sequential cloning of
double-stranded oligonucleotide cassettes into the pUC18 multiple cloning se-
quence (see Fig. 7). Complementary single-stranded oligonucleotides were
treated by T4 polynucleotide kinase in the presence of 1 mM ATP, heated to
70°C for 5 min, and slowly cooled to room temperature. The specific comple-
mentary pairs were 59-ACCGTCTTCGGTG-39 and 39-TGGCAGAAGCCAC-59
for the E2 binding site (E2BS-10, [26]), 59-ATTGTTGTTAACAATAAT-59 and
39-TACAACAATTGTTATTA-59 for the 18-bp E1 binding palindrome (IR)
(22), and 59-GATCTAAGTAAAGACTATGTATTTTTT-39 and 39-ATTCATT
TCTGATACATAAAAAAGATC-59 for the AT-rich region. Both the E2BS-10
and IR cassettes were blunt-ended, while the AT-rich cassette had BamHI 59
overhanging ends. Initially, the 18-bp IR cassette was cloned into the SmaI site
of pUC18 by standard procedures to generate pE1. Subsequently, the E2BS-10
cassette was cloned into the Ecl136II site of pE1. During screening, clones were
identified with one (pE1E2), two (pE1E2D), or three (pE1E2T) copies of the
E2BS-10 cassette inserted. Finally, the AT-rich cassette was added to pE1,
pE1E2, and pE1E2T by being cloned into the BamHI site of these DNAs to
generate pBATFE1, pBATFE1E2, and pBATFE1E2T, respectively. This re-
sulted in a spacing of 7 bp between the AT-rich element and the 18-bp IR and
a spacing of 11 bp between the 18-bp IR and E2BS-10. All clones were confirmed
by sequencing. Their ability to function as specific templates for in vivo BPV1
DNA replication was examined as described previously (19) by a transient assay
performed into CHO cells electroporated with each construct together with
plasmids pCGEag and pCGE2 (52); these experiments will be described else-
where (32).
DNA preparations used as templates for in vitro replication were obtained (by
a standard alkaline lysis procedure and density equilibrium centrifugation) from
E. coli dam1 cultures so as to be fully methylated on both strands on every
GATC site. Accordingly they were found to be both fully sensitive to the DpnI
enzyme and fully resistant to its isoschizomer MboI.










Expression and purification of viral proteins. BPV1 E2 and the glutathione
S-transferase–E1 fusion protein (GST-E1) were expressed by infecting Sf9 cells
with the appropriate recombinant baculoviruses, as reported previously (4, 43).
In order to purify the E1 protein, GST-E1-infected cells were lysed by hypotonic
shock and the nuclear fraction was extracted in a selective manner by a combi-
nation of a high concentration of salt, a high pH, and a high concentration of Mg,
as described previously (3). Fusion protein was isolated by binding to glutathi-
one-Sepharose beads (Pharmacia), and the beads were washed and finally sub-
mitted to specific proteolysis by incubation in the presence of coagulation factor
Xa at 4°C, as described in reference 4. The supernatant produced contained
mostly soluble E1 (at least 80% pure [Fig. 1, lane 5]); it was always used
immediately (i.e., within the next 2 h) for replication assays, because of the
marked instability of E1 replicative activity. E1 content was determined by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis in parallel to, or even
after, the replication assays.
The E2 protein was extracted as described previously (44): after lysis of
infected Sf9 cells by hypotonic shock at pH 6.2, the nuclear pellet was extracted
by 0.5 M NaCl at pH 7.0. E2 was purified from the clarified lysate by affinity
chromatography, with the help of monoclonal antibody B202 (39) coupled to
protein A-Sepharose (Pharmacia) in the same way as that devised for SV40
large-T-antigen purification (48). A column made with 0.5 mg of pure immuno-
globulin G/1 ml of packed beads allowed us to purify as much as 150 mg of the
E2 protein (extracted from 2 3 108 cells). Fractions were eluted by triethanol-
amine (pH 11) buffer, neutralized immediately by adding a 1/10 volume of 1 M
HEPES (pH 7), brought to 50% glycerol, and stored at 270°C. The eluate (Fig.
1, lane 1) consisted of 90% pure E2 protein, with minor contaminants being
mostly proteolytic products as judged by B202 recognition on Western blots;
DNA binding activity, examined by gel shift assays using a specific oligonucleo-
tide (a 20-mer spanning E2BS-10), was found to be consistent with stoichiomet-
ric association (1 nmol of E2BS-10/nmol of E2 dimer [data not shown]).
We purified the E1-E2 molecular complex (2, 36, 43) from Sf9 cells coinfected
with both E2 and GST-E1 viruses (44). From previous observations we knew that
the E1-E2 complex could be extracted from Sf9 isolated nuclei in the same way
as free E2 protein, i.e., by moderate ionic strength at neutral pH (43), while free
E1 required a much higher pH to be extracted quantitatively (42). A similar
GST-E1-E2 complex, existing in the cells coinfected by the corresponding viruses
(4), was quantitatively extracted in the same way as was E2, leaving free GST-E1
in the remaining nuclear pellet. The GST-E1-E2 complex was further purified by
affinity chromatography with glutathione-Sepharose. Proteolysis by factor Xa,
performed in the same way as was done for preparing E1, led to preparations
consisting mostly of E1-E2 complex (Fig. 1, lanes 2 through 4), which were found
to bind the E2 responsive element in the same way as did E2 alone (not shown).
In vitro assays for DNA replication. Soluble extracts for cell-free replication
were prepared as described previously (23). Assays were performed as already
described (3, 4) by incubating cell extract of various sources (200 mg of total
proteins) and template DNA (either 0.15 mg of pSKori- and pUC-derived con-
structs or 0.25 mg of pSV-BPV1 DNA) together with viral proteins (usually 50
ng of E2 and 150 ng of E1) in a volume of 50 ml under standard conditions (50)
at 37°C for the indicated times (60 min or more). The extent of DNA synthesis
was monitored by counting the incorporation of [32P]dCMP into acid-insoluble
material. DNA products were further purified and analyzed as described previ-
ously (4); autoradiograms were scanned with the help of an LKB Ultroscan
densitometer.
RESULTS
E2 does not greatly affect E1-dependent cell-free BPV1 DNA
replication. We initially obtained efficient cell-free DNA rep-
lication by using extracts of COS1 SV40-transformed monkey
cells and a composite DNA template (pSV-BPV1) carrying
the SV40 and BPV1 origins of replication (3, 4) together with
viral protein preparations. This in vitro system allowed us to
directly compare the replication processes driven by either
BPV1 protein E1 or SV40 large T antigen; in both cases,
similar levels of in vitro DNA synthesis were reached through
the succession of several rounds of bona fide replication. Other
cell types were found to provide soluble extract of similar
properties: extract from human 293 cells sustained cell-free
BPV1 DNA replication with the same characteristics and the
same yield, amounting to 0.5 daughter molecules/template
molecule for a ratio of only 10 to 15 E1 molecules/DNA tem-
plate molecule. Results were further extended to another
DNA template, pSKori1, carrying a short BPV1 sequence of
only 160 bp surrounding the replication origin. As shown in
Fig. 2, a succession of replicative rounds took place during the
90 min of incubation, as detected by the susceptibility of the
newly synthesized DNA to the MboI enzyme, whose cleavage is
restricted to nonmethylated GATC sites (present only on
daughter molecules resulting from at least two rounds of syn-
thesis); MboI digestion resulted not only in a shift from slow-
migrating replicative intermediates to faster forms but also in
the appearance of the full set of pSKori MboI fragments.
Adding purified E2 protein to the in vitro assays performed
with the pSKori1 template with a constant amount of baculo-
virus-expressed E1 protein in the presence of 293 cell extract
(Fig. 2) did not greatly modify either the level of synthesis or
the susceptibility of the newly-made DNA products to MboI
digestion. A dual effect was reproducibly found for E2: low
amounts of E2 produced a small increase in the overall extent
of replication, in any case larger than 1.5-fold under our con-
ditions, with optimal replication observed for an apparent stoi-
chiometry lower than 1 E2 molecule/2 E1 molecules (consid-
ered monomers), while higher amounts of E2 resulted in
partial inhibition, the extent of which depended especially on
the template (see below and Fig. 8). E2 exerted the same dual
effect upon second rounds of DNA synthesis. Low E2 amounts
enhanced the labeling of MboI fragments somewhat more than
they did for total synthesis; this might be explained in a simple
way by hypothesizing that E2 should help stabilize active E1
molecules, an effect expected to be particularly marked for
delayed events, as are the second rounds of synthesis.
E2 appeared thus to have only a marginal effect on cell-free
BPV1 DNA replication. This was discrepant with results re-
ported by others (37, 47, 58, 59), who observed large stimula-
tion factors (at least fourfold) with overall cell-free DNA syn-
thesis much less active than ours, by using extracts from mouse
FM3A cells. Reasoning that we might have left undetected a
larger E2 effect by using concentrations of active E1 protein
that were too high, we performed another set of in vitro assays
in which we varied the amounts of E1 while keeping E2 con-
stant; the experiment (Fig. 2c) confirmed our previous results:
no effect of E2 on DNA synthesis was detected at any concen-
tration of E1. In the same way, we purified the E1-E2 complex,
formed in insect cells before extraction (see Materials and
Methods and Fig. 1), for which we found the same capacity to
sustain pSKori1 DNA synthesis in vitro as for E1 protein
alone: similar amounts of protein yielded almost identical lev-
els of synthesis (see Fig. 5). Moreover, the DNA products
exhibited the same susceptibility to the MboI or DpnI restric-
tion enzyme (data not shown). Thus, under in vitro conditions
FIG. 1. Purified E1, E2, and E1-E2 complex. Proteins were expressed in Sf9
cells by infection with the appropriate baculovirus vector(s), purified by affinity
chromatography as described in Materials and Methods, and analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and Coomassie staining. Lane
1, E2 obtained by eluting a B202 monoclonal antibody column; lanes 2 to 4,
successive steps of glutathione-Sepharose chromatography used to purify the
E1-E2 complex (lane 2, proteins bound to affinity beads from an extract of insect
cells coinfected by two recombinants expressing both E2 and the GST-E1 fusion
protein; lane 3, the same material incubated for 4 h with factor Xa; lane 4,
supernatant obtained from the same digestion); lane 5, E1 protein purified by a
similar procedure; lane MK, molecular size markers.










allowing high replicative activity for the E1 protein alone, the
E2 protein fails to stimulate the BPV1 DNA replication pro-
cess significantly.
E2 does not complement defective mouse cell extracts. As
previously reported (4), in the presence of E1 only, the mouse
cell extracts employed in most other studies for supporting
BPV1 DNA replication in vitro were found to be significantly
less active than extracts from monkey COS1 or human 293
cells: dCMP incorporation values for the mouse cell extracts
were lower by a factor of 5 to 10 (Fig. 3), and, more impor-
tantly, DNA synthesis did not result in semiconservative for-
mation of mature DNA molecules as assessed by resistance to
the DpnI enzyme. Since the stimulation by E2 of BPV1 DNA
synthesis had been observed in experiments performed with
mouse cell extracts, we reasoned that an E2-like factor, capa-
ble of exerting the same effect as the E2 protein on E1-driven
replication processes, might be present in COS1 or 293 cells
but missing from mouse cells. We thus compared the effects of
E2 on BPV1 DNA replication in in vitro assays using extracts
from various species. As visible in Fig. 3, E2 produced much
greater stimulation of dCMP incorporation with extract from
mouse ts85 cells (a cell line derived from FM3A cells) than
with 293 cell extract; as ts85 extract allowed much weaker
synthesis in the absence of E2, the maximal levels of incorpo-
ration were the same for both extracts. Moreover, the analysis
by gel electrophoresis of the newly made DNAs indicated a
clear difference in the replicative intermediates (RI): the use of
mouse extract resulted in products migrating close to form II
DNA, presumably replicated on very short distances, while the
RIs produced with the help of 293 cell extract migrated much
more slowly. Furthermore, in the latter case the labeling of
form I molecules was stronger.
Figure 4 shows the results of another experiment, performed
in order to determine whether E2 would improve the capacity
of mouse cell extract to sustain semiconservative synthesis of
full-sized DNA molecules and second rounds of replication.
While extracts from both COS1 and 293 cells allowed produc-
tion of slow-migrating RIs, DpnI-resistant form I molecules,
and MboI-susceptible new DNA molecules, this was clearly not
the case for the extract from mouse ts85 cells. These results
indicated that the stimulatory effect of E2 on dCMP incorpo-
ration observed with cell extract from mouse origin did not
reflect a bona fide process of DNA replication but rather some
irrelevant phenomenon of either incomplete or repair-like
DNA synthesis.
E2 suppresses E1-dependent nonspecific replication of ori-
defective DNAs. An important effect exerted by E2 on cell-free
DNA synthesis was revealed by using template molecules de-
void of a functional origin of replication. As already reported
(3), high concentrations of protein E1 sufficed to sustain rea-
sonable levels of DNA synthesis with even nonspecific tem-
plates like pUC18 DNA (see below). When usual assay mix-
tures (containing E1, 293 cell extract, and DNA) were
complemented by E2 in an amount which would result in
maximal synthesis in the case of specific templates (as for
pSKori1 DNA), the replication of nonspecific DNA templates
was almost totally inhibited, down to the background level
observed in control incubations devoid of E1 (data not shown;
also see Fig. 6 and 7). The same effect was observed when we
compared the activities of the E1 protein and the E1-E2 pre-
formed complex (Fig. 5) on two DNA templates carrying either
the wild-type or a mutated BPV1 origin of replication: in the
case of the ori1 template, comparable levels of DNA synthesis
were obtained for similar amounts of either protein prepara-
tion; in the case of ori-defective DNA, remarkably, only back-
ground levels of incorporation were measured for any E1-E2
amount, while efficient DNA synthesis took place with E1, at
least for high protein concentrations. This effect was further
examined by assessing the susceptibility to the DpnI enzyme of
the products of cell-free synthesis obtained with ori-defective
DNA (Fig. 6). With pUC18 DNA as a template with 293 cell
extract, parallel incubations containing comparable amounts of
a mixture of either E1 and E2, the E1-E2 complex, or E1 only
were run for various times at 37°C; while some labeling is
FIG. 2. Effect of E2 on E1-dependent BPV1 DNA replication in vitro. Assays were performed as described in Materials and Methods by incubating pSKori1
template DNA in the presence of 293 cell extract and purified E1 and E2 proteins as indicated for 90 min at 37°C. (a) Relative values for DNA synthesis obtained by
using a fixed amount of protein E1 (150 ng) and various amounts of protein E2, as indicated. Closed circles, incorporation of radioactive dCMP into trichloroacetic
acid-precipitable material; open squares, densitometric estimate of the labeling of the MboI fragments in the gel shown in panel b. (b) The labeled DNA products were
purified and analyzed by agarose gel electrophoresis either directly (30% of every sample) or after exhaustive cleavage by the MboI restriction enzyme (60% of every
sample), as indicated on the top of the autoradiogram; in the margin, marked positions indicate RI and closed circular molecules (fI0). (c) Total synthesis as described
for panel a but with various amounts of E1 in the absence (open circles) or with a constant amount (50 ng; closed circles) of the E2 protein.










visible in DpnI fragments (even for the assays containing E2
proteins), form I DNA molecules resistant to the enzyme,
indicative of complete semiconservative synthesis, were ob-
tained for the late incubation time but only in the absence of
E2. E1 is thus able to sustain bona fide replication of nonspe-
cific DNA molecules in vitro, although to a lower degree than
for the true ori template. This is possible, however, only in the
absence of the E2 protein, which acts in vitro as a specificity
factor to restrict the action of E1 to proper origin sequences.
Specific origins of BPV1 DNA replication in vitro do not
need to carry an E2 binding site. We wanted to identify the
cis-acting elements present within the origin of replication that
specifically allow E1-driven DNA synthesis in the presence of
E2 to start. A set of constructs was made by successively in-
serting into the multiple cloning site of pUC18 DNA modular
elements corresponding to three functionally distinct se-
quences forming the 62-bp ori DNA sufficient for BPV1 rep-
lication in vivo (Fig. 7): the 18-bp palindromic E1 binding site,
an AT-rich 22-bp sequence, and an E2 binding site, aligned in
the same order as in the BPV1 genome. This resulted in syn-
thetic putative origins, containing or lacking either the AT-rich
sequence or the E2 binding site. These DNA constructs were
assayed for the capacity to replicate transiently in transfected
cells expressing in trans both the E1 and E2 proteins. The
results, to be published in detail elsewhere (32), are summa-
rized in Fig. 7; they clearly verified that the presence of each
one of the three ori components is required in vivo for repli-
cating viral DNA, thus evidencing the modular structure of the
BPV1 replication origin. Although the constructs differed from
the wild-type origin both by the spacing between the three
elements and by the strength of the E2 binding site, a situation
which might explain lower replication rates, their replication in
vivo was found to require at least one E2 binding site; more-
over, increasing the number of E2 sites noticeably improved
replication levels.
We used these constructs as templates in cell-free replica-
tion assays. As E1 or E1-E2 preparations vary somewhat in
replicative efficiency and have to be used immediately, all con-
structs were assayed in parallel with the same protein prepa-
rations to allow direct comparison between templates. The
incorporation of radioactive dCMP into DNA was measured
and is presented in Fig. 7; in addition, DNA products were
FIG. 3. Comparison of BPV1 DNA synthesis obtained in vitro by using
extracts from either mouse ts85 cells (open circles) or human 293 cells (closed
circles). Similar amounts of soluble extracts were incubated for 2 h in the
presence of 0.15 mg of pSKori1 DNA and 170 ng of protein E1 with various
amounts of E2 as indicated. Upper panel, relative levels of dCMP incorporation
normalized to that observed for E1 alone in the presence of 293 cell extract.
Lower panel, analysis by agarose gel electrophoresis of the labeled products from
the same experiment. fI0, closed circular DNA molecules.
FIG. 4. BPV1 DNA synthesis sustained in vitro by various cell extracts in the
presence of the E1-E2 complex. Incubations (90 min at 37°C) were performed in
the presence of purified E1-E2 complex (corresponding to ca. 150 ng of protein
E1) and similar amounts of extracts from 293, COS1, or ts85 cells by using
pSKori1 DNA as a template. Purified DNA products were then submitted to
exhaustive digestion with either the DpnI or MboI restriction enzymes (isoschi-
zomers sensitive to adenine methylation in opposite ways, as discussed in the
text) and analyzed by agarose gel electrophoresis as indicated. Lanes A, B, and
C correspond to extracts from COS1, 293, and ts85 cells, respectively. fI0, closed
circular DNA molecules.
FIG. 5. DNA replication performed in vitro in the presence of the E1-E2
complex is restricted to templates carrying a specific origin of replication. Parallel
incubations were performed in the presence of 293 cell extract with the addition
of either purified protein E1 (closed symbols) or the E1-E2 complex (open
symbols, corresponding to similar amounts of protein E1, i.e., 150 ng) with either
pSKori1 (circles) or pSKori2 (squares) DNA template. At the times indicated,
aliquots were taken, submitted to trichloroacetic acid precipitation, and counted.










purified and analyzed by DpnI digestion in order to assess the
semiconservation of synthesis. E1 concentration was kept high
enough to allow replication of both specific (pSKori1) and
nonspecific (pUC18) templates in the absence of E2; this may
explain some variability within the same experiment (ca. 20%).
Two types of ori constructs might be distinguished in the assays
performed with E1 only: (i) those replicating with low effi-
ciency (less than 25% of that found for the wild-type ori tem-
plate) and lacking either a functional E1 binding site (pS-
Kori2) or an AT-rich element (pE1 and pE1E2, etc.), and (ii)
those replicating at levels close to that of the wild type, for
which an E2 binding site was dispensable, a result that was not
surprising since the assays were performed in the absence of
E2. Although within each class of constructs some variation
can be seen, which might simply reflect variability in the assays,
the differences between the two classes were marked enough to
be considered significant. Only two ori elements, therefore,
likely provide for efficient DNA replication in vitro in the
absence of E2: the E1 binding site, allowing recognition of
DNA templates by the initiator protein, and the AT-rich se-
quence, likely helping to easily unwind the origin DNA.
In the presence of E2, the same elements were indeed re-
quired and the constructs could be classified according to their
ability to replicate in vitro in an order confirmed by similar
results obtained with the E1-E2 complex. When AT-rich or E1
binding sequences were lacking in synthetic ori (as in pSKori2
and pE1E2, for instance), precursor incorporation dropped
dramatically to background levels, and DpnI-resistant form I
DNA was no longer detectably made in vitro. In the opposite
way, an origin reconstituted from its three elements
(pBATFE1E2) was replicated to lower levels than wild-type
pSKori1 but with detectable production of DpnI-resistant cir-
cular molecules. Surprisingly enough, the same construct lack-
ing an E2 binding site (pBATFE1), which was unable to sup-
port replication in vivo, still provided higher levels of synthesis
in vitro. As was also the case for transient replication in trans-
fected cells in vitro, in the presence of E2 the replication levels
were always lower for synthetic templates than for wild-type ori
DNA; this is likely due to either improper spacing between
individual elements (e.g., the E1 binding site and AT-rich
sequence), the use of a high-affinity E2 binding site (as dis-
cussed further below), or both. The results obtained both in
vivo and in vitro for pBATFE1E2, pBATFE1, pE1, and pE1E2
can, however, be directly compared, allowing simple conclu-
sions. In vitro, E2 clearly helps E1 to distinguish specific tem-
plates which possess both an E1 binding site and an AT-rich
element from nonspecific DNAs; moreover, discrimination
may occur in the absence of an E2 binding site on the template
molecule. This suggests that in PV DNA replication, E2 has
the capacity to play the role of a specificity factor, a function
that, under our conditions, is likely not mediated by direct
recognition of DNA. Cell-free experiments cannot tell us
whether this new property is biologically important for the
virus or not; it appears, however, to be distinct from the func-
tion that E2 has to play in vivo, which requires the presence of
an E2 binding site within the origin (55) (Fig. 7).
E2 inhibits the cell-free replication of DNA templates car-
rying numerous or high-affinity E2 binding sites. Another
unexpected finding is visible in Fig. 7: increasing the number of
E2 binding sites in the ori constructs decreased their efficiency
to function in vitro as templates for replication in the pres-
ence of both the E1 and E2 proteins. The level of in vitro
synthesis varied inversely with the number of E2 binding
sites in the origin (compare pBATFE1, pBATFE1E2, and
pBATFE1E2T). The behavior of the construct carrying
three E2 binding sites was striking: it replicated best in vivo; in
vitro, its behavior in the absence of E2 was found to be very
similar to that of the wild-type origin template. However, in the
presence of E2, we could not detect any significant semicon-
servative replication (i.e., formation of DpnI-resistant circles).
This result can be interpreted in several ways; it must be noted,
however, that the E2 binding sequence used here for construct-
ing synthetic origins (E2BS-10) is recognized with high affinity,
while the site normally present in the wild-type origin (E2BS-
12) binds E2 poorly (26). It appears likely that replacing the
low-affinity E2 binding site adjacent to the E1 palindrome by a
high-affinity one has a negative effect on the efficiency of cell-
free replication performed in the presence of protein E2. This
is also visible (Fig. 7) by comparing pBATFE1 (no E2 binding
site) to pBATFE1E2 (one E2 binding site). High-affinity bind-
ing of protein E2 by DNA targets, especially when numerous
on the DNA template molecule, seems to inhibit in vitro the
process of initiating replication triggered by the BPV1 E1
protein.
Active E1 molecules are capable in theory of building up
molecular complexes with E2, and we know that this was in-
deed the case in cell-free conditions, as shown by the specificity
effect by which E2 helped to recognize proper ori sequences.
As a likely explanation for the negative cis effect exerted by the
presence of numerous and/or high-affinity E2 sites on template
DNA, we reasoned that these sites might engage E1-E2 com-
plexes into some form of nonproductive DNA binding. E2-
mediated binding to these sites would block E1 in the wrong
position or conformation, rendering it unable to bind further
or to unwind the ori DNA duplex. This hypothesis was rein-
forced by the following experiment (Fig. 8): pSV-BPV1, which
carries in addition to the 160-bp ori sequence present in pS-
Kori1 2.7 kb of flanking BPV1 DNA with 12 additional E2
binding sites (most of them recognized with high affinity), was
used in vitro as a template in parallel assays containing increas-
ing amounts of E2 protein. As a result, DNA synthesis de-
FIG. 6. The replication of an ori-defective template DNA, supported to some
extent by the presence of E1 alone, is suppressed by the addition of E2. Repli-
cation assays were performed by using pUC18 DNA as a template in the pres-
ence of E1 (150 ng) with or without E2 (50 ng) or the E1-E2 complex (corre-
sponding to 150 ng of E1), as indicated. Aliquots were taken at increasing
incubation times (15, 30, 60, and 90 min), and the DNA was purified, submitted
to exhaustive digestion with the DpnI restriction enzyme, and analyzed by aga-
rose gel electrophoresis.










creased strikingly in a dose-dependent manner, down to back-
ground incorporation levels (obtained for E2 amounts which
otherwise would have resulted in optimal synthesis if the short
ori construct pSKori1 were used).
DISCUSSION
Under cell-free conditions allowing replication of BPV1
DNA with high efficiency with the help of viral protein E1 (3,
4), we observed that the presence of viral protein E2 produced
only marginal effects, both on the synthesis level and on the
frequency by which second rounds of replication were reiniti-
ated (less than 1.5- and 3-fold stimulation at best, respectively
[Fig. 2]). These results were obtained by using a DNA template
(pSKori1) carrying only a short BPV genomic fragment, which
precisely covers the minimal sequence previously defined as
being the origin of viral DNA replication (19, 34, 53, 55, 56).
This is at variance with most previous studies on cell-free
BPV1 DNA replication (37, 47, 58, 59) performed by using a
comparable template (pKSO) which reported significant stim-
ulation by E2 of DNA synthesis; enhancement by E2, varying
considerably but being always greater than fourfold, never
resulted in levels of synthesis as high as those we report here.
This discrepancy with our present results might likely be ex-
plained by the use of inadequate cell extracts (a point to be
discussed later) and of partially inactive E1 preparations. As
already noted (4), active E1 preparations, able to sustain cell-
free DNA synthesis as efficiently as SV40 large T antigen, were
found to be especially unstable, with replicative capacity drop-
ping dramatically through successive chromatographic steps or
upon storage at 4°C (as performed in most other studies). We
also noted that the extraction procedures used in other studies
resulted in only partial solubilization of protein E1 (43) and
might thus have selected E1 subspecies of peculiar character-
istics.
We are confident in the significance of our results, showing
only marginal stimulation by E2 protein of cell-free BPV1
DNA synthesis, for three reasons. First, the lack of significant
stimulation is unlikely to result from artifactual inactivity of E2
preparations, because these were checked for proper DNA
binding. Also of note, we prepared E2 from baculovirus-in-
fected insect cells by a technique widely used by others, who
FIG. 7. Replication of DNA templates carrying variously reconstructed replication origins. In addition to pSKori1 (which contains 160 bp of BPV1 DNA sequence,
indicated by a continuous black line, spanning the 62-bp minimal ori sequence and carrying the E2 binding site E2BS-12, making up part of the ori sequence, and an
additional site for E2, E2BS-11) and pSKori2 (obtained by disrupting the E1 binding site by linker insertion), various constructs were made by inserting within the
polylinker of the pUC18 bacterial vector (hatched line) three oligonucleotides from the BPV1 sequence: the 18-bp E1 binding site (E1BS) (open rectangle), the AT-rich
element (striped rectangle), and an E2 binding site (E2BS-10, nt 7781 to 7792) (small black rectangle) (see Materials and Methods). These constructs were used as
templates in parallel assays for in vitro DNA synthesis performed by using 293 cell extract with the aid of either protein E1 (alone or with addition of E2) or the E1-E2
complex (90-min incubation at 37°C with the same protein amounts as given in the legend to Fig. 6). DNA synthesis was evaluated by measuring the incorporation of
radioactive dCMP into trichloroacetic acid-precipitable material and presented here relative to the value obtained for pSKori1 in the presence of E1 alone (taken as
100%, with all values being first subtracted for the background incorporation measured in a control assay in the presence of extract alone). In the experiments performed
with separately purified E1 and E2 proteins, labeled DNA products were also purified, submitted to extensive digestion with the DpnI restriction enzyme, and analyzed
by gel electrophoresis; the production of labeled full-sized circular DNA molecules entirely resistant to DpnI being indicative of semiconservative replication, the
presence and intensity of a corresponding band is marked here by “1,” “2,” and “6” symbols on the right side of each column. Experiments were performed in parallel
to evaluate the capacity of the DNA constructs to be used as templates for replication in vivo by transfecting them into mouse C127 cells (together with plasmid
constructs helping to express both the E1 and E2 proteins) and examining them 48 h later for the presence of DpnI-resistant full-sized circular molecules by Southern
blot analysis, as shown in the right-hand column (to be detailed elsewhere [32]).
FIG. 8. Inhibition by E2 of the in vitro replication of a template carrying a
3-kb BPV1 DNA fragment, which contains 13 binding sites for E2 in addition to
the minimal ori sequence. Replication assays were performed by using 0.25 mg of
pSV-BPV1 DNA (see text) as a template in the presence of 180 ng of protein
E1 and various amounts of protein E2 (closed circles, open circles, open squares,
and closed squares represent 0, 25, 50, and 100 ng of E2, respectively). Aliquots
(10 ml) were taken at various times of incubation, submitted to trichloroacetic
acid precipitation, and counted.










reported stimulatory effects (58, 59); our results can thus
hardly be explained by the lack of proper posttranslational
modifications of the E2 protein. Second, similar results were
obtained when titrating a constant amount of E1 with various
amounts of E2 and vice versa (Fig. 2a and c). Last, we did not
find significant differences in cell-free replication of specific
DNA templates when using either E1 protein only, a mixture
of E1 and E2, or, significantly, preparations of the in vivo-made
complex between the two proteins (Fig. 5 and 7). As likely
explanations for the significant stimulation by E2 observed in
previous studies, we can imagine either some kind of stabili-
zation (or partial reactivation) of protein E1 provided by in-
teraction with E2 or a more specific effect occurring for a
molecular subspecies of E1, whose conformation or posttrans-
lational modification may differ from that of the E1 protein
responsible in our assays for high DNA synthesis. In agreement
with the first hypothesis, small E2 amounts appeared to pref-
erentially stimulate second rounds of replication (Fig. 2).
Consistent with the second hypothesis, Melendy et al. re-
cently reported that the same soluble extract from 293 cells
failed to support DNA synthesis in the presence of bacterially
expressed E1 protein (33). Replacing the extract by partially
purified protein fractions from the same source, however, sus-
tained vigorous BPV1 DNA replication at levels comparable to
those we report here; notably also, only low stimulation by E2
was observed (less than threefold), occurring only for low E1
concentrations. It is worth noting that none of the purified
proteins sufficing for in vitro reconstitution of the whole pro-
cess of SV40 DNA replication were able to replace the un-
known factor(s) missing in the 293 cell extract. We have veri-
fied that, while having normal ATPase and DNA-binding
activities (44), bacterial E1 was not able to sustain any detect-
able DNA synthesis in the presence of 293 cell extract (data
not shown), as seen by Melendy et al. (33). Comparing both
sets of results suggests that the E1 protein produced in bacteria
might lack critical posttranslational modification, possibly
phosphorylation, since in mammalian cells E1 is phosphory-
lated on both N- and C-terminal sites (42, 51). Sequence sim-
ilarities between E1 and SV40 large T antigen (10, 38), espe-
cially for putative phosphorylation motifs, together with the
fact that SV40 DNA replication depends on the T-antigen
phosphorylation state (20, 35), may support this hypothesis.
The second point at variance with most previous works is the
source of cell extract we used for performing the in vitro assays.
Extracts prepared from several mouse cell lines, especially the
FM3A cells used by others for in vitro studies of BPV1 DNA
replication as well as an FM3A mutant (ts85), did not support
E1-dependent DNA synthesis as efficiently as did 293 or COS1
cell extracts (4): dCMP incorporation values were in the range
of those measured by others, i.e., less than 20% of those pro-
vided by “permissive” 293 cell extract. Moreover, although
DNA synthesis strongly depended on E1, it did not proceed
through semiconservative replication up to complete mole-
cules (Fig. 4). While adding E2 to assays performed with
mouse cell extract enhanced dCMP incorporation, it did not
improve the quality of DNA synthesis; as shown by its electro-
phoretic migration and susceptibility to the DpnI restriction
enzyme, newly made DNA might have resulted either from
abortive replication starting from accurate initiation events or
even from irrelevant repair-like replacement synthesis. The
process by which DNA synthesis was supported by mouse cell
extract thus could hardly be considered genuine replication,
that is, semiconservative synthesis of complete DNA mole-
cules, even in the presence of E2.
We found, however, that E2 was able to exert a specific
effect upon BPV1 cell-free DNA synthesis by suppressing the
nonspecific replication of ori-defective templates. As already
seen by others (47, 59), nonspecific DNA was also found to be
a template for cell-free DNA synthesis in the presence of high
E1 concentrations (4) (Fig. 5 to 7); the process can be consid-
ered genuine DNA replication, at least in part since it was
producing DpnI-resistant form I molecules (Fig. 6). It was
completely abolished by replacing E1 with the E1-E2 complex
(Fig. 5) or by adding E2 to the in vitro assays (Fig. 6). This
observation defines a new role for E2, that of being a specificity
factor for BPV1 DNA replication, as already suggested by
others (22, 58). By using the same 293 cell extract for replicat-
ing HPV11 DNA, Kuo et al. (22) noted also that the presence
of both BPV1 E1 and E2 proteins did not allow cell-free
replication of pUC19 DNA. At discrepancy with our findings,
however, their data were consistent with a need for E2 in order
to replicate ori1 DNA. The difference might be explained by
the use of distinct experimental conditions: Kuo et al. used
long preincubation steps, relying on kinetic peculiarities of the
HPV11 system that we know not to apply to BPV1 (see refer-
ence 3). Such steps might be unsuited for keeping E1 in the
active form needed to provide high-efficiency BPV1 DNA rep-
lication, allowing only the weak DNA synthesis observed in
most previous works; this might explain, as a corollary, the
large stimulatory effect of E2 recently reported by these au-
thors (27).
In addition to this specificity effect, we also observed that
high E2 concentrations might exert a negative effect on ori1
DNA replication (Fig. 2 and 3) similar to that previously noted
by others studying cell-free synthesis of BPV1 DNA under
conditions of low efficiency (29). Comparably, we observed
strong inhibition by E2 of cell-free DNA replication for DNA
templates carrying either a second high-affinity E2 binding site
near the origin or multiple E2 binding sites located at a dis-
tance (Fig. 7 and 8). This effect might represent an artifactual
phenomenon peculiar to cell-free replication resulting from
trapping initiator protein E1 into nonproductive complexes
with E2; such complexes, once bound to irrelevant E2 sites
through their E2 moiety, would prevent further initiation by
E1, since the proper DNA context (i.e., an E1 binding site and
AT-rich element) for triggering DNA synthesis would not ex-
ist. On the other hand, this negative effect might well corre-
spond to a physiological mechanism by which E2 would help to
limit the extent of viral DNA replication. This hypothesis,
however, is rendered unlikely by the opposite behaviors ob-
served for synthetic ori’s like pBATFE1E2 and pBATFE1E2T
in vitro and in vivo (Fig. 7): adding two more E2 binding sites
to pBATFE1E2 DNA improved replication in vivo, while it
depressed in vitro synthesis. Definitive conclusions on the na-
ture of the inhibitory effect exerted by E2 on cell-free BPV1
DNA synthesis would require however a more detailed exam-
ination, especially by using other ori constructs.
Under the cell-free conditions allowing high levels of BPV1
DNA synthesis, we found that only two sequence elements
were both required and sufficient for defining a specific origin
of replication (Figure 7): an E1 binding site and an AT-rich
element. As expected from previous results, E2 increased the
stringency of ori recognition by suppressing the replication of
template molecules devoid of either element; it did not appear
to qualitatively change the sequence requirements, however.
Strikingly, the absence of an E2 binding site did not seem to
affect the capacity of ori DNA to be replicated in vitro in the
presence of E2, while the lack of an AT-rich sequence abol-
ished it. The latter element might be more important than yet
suspected: for relaxed initiation of DNA synthesis (i.e., in the
absence of E2), the lack of an AT-rich element in synthetic ori
templates had the same negative effect as mutating or remov-










ing the E1 binding site (compare the pSKori1 and pSKori2
and the pBATFE1E2 and pE1E2 pairs). In this respect, the
uneven labeling distribution along ori-negative templates
might also be significant. For pUC18 DNA (Fig. 6), preferen-
tial labeling occurred in a particular DpnI fragment (third from
the top, nt 1662 to 2003, numbered as in reference 60); this
fragment is the nearest to the most AT-rich sequence in
pUC18 (nt 1563 to 1593, with 28 AT pairs contained in a very
short fragment excluded from the gel). This may suggest that in
the absence of E2, E1 is able to initiate bona fide replication on
any naked DNA molecule by taking advantage of AT-rich
stretches of nucleotides; nonspecific initiation events occur at
low frequency, however, being detected only for high E1 con-
centrations. In the presence of E2, the action of E1 is restricted
to specific ori DNA by binding the 18-bp ori palindrome and
requires an adjacent AT-rich element for initiating DNA syn-
thesis. This second element likely helps for proper DNA un-
winding, but this point needs to be addressed in detail. E2
binding sites are not required for and even do not seem to
improve the initiation of viral DNA synthesis by E1 under our
cell-free conditions. In the same manner, E2 does not seem to
limit the action of E1 to the sole ori sequences carrying E2
binding sites.
The observation that no E2 binding site was needed in order
to build an in vitro functional BPV1 origin of replication was
discrepant with another recent cell-free study (45) showing
that origin recognition occurred through concomitant binding
of E1 and E2, interacting as a molecular complex, to adjacent
E1 and E2 binding sites and that both sites were required (with
proper strength and spacing) for defining a functional origin.
As already discussed, different conclusions might reflect differ-
ent experimental conditions, likely to correspond to distinct
replication modes. In order to carefully reconstitute in vitro
DNA synthesis with the same requirements as those shown by
in vivo replication of viral plasmids, Sedman and Stenlund (45)
used both bacterial E1 and mouse FM3A cell extract, with the
result of only very low levels of DNA synthesis. Moreover, in
order to suppress nonspecific initiations by E1, their assays
were performed in the presence of competitor DNA, poly(dA-
dT), that we found to inhibit the high-efficiency cell-free DNA
replication supported by 293 cell extract (not shown). It is thus
unlikely that we were examining the same process as did Sed-
man and Stenlund. On the other hand, the properties of the
E1-E2 complex might vary depending on E1 conformation or
modification; in this respect, as we used especially active E1
preparations, it is tempting to speculate that the corresponding
E1 form might interact with E2 in a special way, forming a
complex capable of stringent recognition of ori sequences in
the absence of an E2 binding site. This hypothesis would also
apply for the E1-E2 complex of similar properties made in
insect cells. This question requires further examination. An-
other point raised by the work of Sedman and Stenlund (45) is
the importance of proper spacing and/or sequence context for
allowing E1-E2 cooperative action. By using synthetic origins
not entirely fulfilling this requirement, we might have left un-
detected an important contribution of a properly located E2
site to the process of ori recognition; this also would require a
more detailed examination by using another set of ori con-
structs made of the same elements properly spaced and having
the conserved spacer sequences in between. The imperfect
structure of our synthetic origins raised a more general ques-
tion, that of the biological relevance of the observations made
with their use. This is a limitation common to all in vitro
systems reproducing a cell molecular process, but cell-free
studies have the important virtue of clearly revealing the bio-
chemical capacities of the various participants to the process.
In this respect, our results strongly suggest that, by virtue of
interacting with active E1 molecules in a proper molecular
context for sustaining highly efficient BPV1 DNA synthesis
(293 cell extract), E2 has the capacity to ensure specific rec-
ognition of replication origins, even in the absence of a cognate
binding site at the origin.
How could E1-E2 interactions result in more stringent rec-
ognition of the BPV1 replication origin in the absence of any
E2 binding site within the origin? The evidence suggests that
the molecular association between both proteins may reduce
E1 capacity, either to be stably bound to or to unwind nonspe-
cific DNA. If so, DNA binding by E2 might represent a dis-
pensable function in the process of viral DNA synthesis, a
proposal consistent with the properties of two E2 mutants
devoid of DNA binding activity but able to support, together
with E1, viral DNA replication (15, 57). Direct binding of E2
to a cognate site near the origin, however, is critical for allow-
ing efficient replication in vivo, as shown by the pBATFE1
construct, devoid of an E2 binding site, found to be an efficient
template for replication in cell-free assays but not in vivo in
transiently transfected cells (Fig. 7). In addition to being a
specificity factor ensuring accurate recognition of defined se-
quences as viral origins (the only function we have discovered
in vitro by working on naked DNA templates), E2 has indeed
to play another role in vivo. This second, mandatory function
is likely similar to that ensured by host transcription factors in
the case of polyomavirus DNA replication, as documented
previously (24, 25).
To reconcile all data obtained to date by in vitro studies of
BPV1 DNA synthesis, we propose, as a simple working model,
that E1 might sustain cell-free replication in two ways. (i) In a
low-efficiency mode, apparently limited to only one round of
replication and mostly producing incomplete molecules, syn-
thesis is enhanced by the presence of E2, an effect which
requires an E2 binding site as a component of the replication
origin. (ii) In a high-efficiency mode of DNA replication, pro-
ceeding through successive rounds of synthesis up to complete
circular molecules, the presence of E2 has only a marginal
effect, as shown here. A critical parameter for determining
which sort of cell-free synthesis could be driven by E1 is the cell
type used for preparing soluble extract. Another parameter is
E1 itself, whose full activity would require a proper molecular
state, as yet undefined but likely to involve posttranslational
modification and specific conformation. In both modes, DNA
synthesis is not limited to specific ori templates. In this respect,
however, our results also show that E2 restricts the initiation
events to specific origins; they further suggest that this property
might not require the presence of an E2 binding site at the
replication origin, as it is likely mediated primarily by interac-
tions between proteins E1 and E2 (at least for the high-effi-
ciency mode). The biological relevance of the two modes of
cell-free BPV1 DNA synthesis remains to be examined. They
do, however, mimic the in vivo situation: during the differen-
tiation of infected keratinocytes within viral neoplasms, the PV
genomes undergo two successive modes of replication, the first
one being limited to the maintenance of viral plasmids and the
second one corresponding to endless runaway synthesis. Char-
acterizing the critical parameters defining the mode of cell-free
DNA synthesis, that is, identifying the proteins present in
mouse or 293 cell extracts which may act as positive or negative
regulators of E1 function, might shed light on the mechanism
of the shift between the two modes of PV DNA replication.
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